During the last decade gene expression profiling studies have established a molecular taxonomy of breast cancer defining four intrinsic molecular groups with clinical relevance: luminal A, luminal B, HER2+, and basal-like [1], [2], [3]. This evidence concerns the gene ERBB2 and breast cancer.